FDA Inspection
The American National Red CrossThe American National Red Cross – FDA Inspection, Jun 27, 2023
Record Details
This FDA Inspection record concerns The American National Red Cross, with an inspection on June 27, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 9c077ae0-8400-472a-ba5e-e0931e072635
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1208889
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The American National Red Cross
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 10, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 18, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 17, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 16, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The American National Red Cross
- FDA Inspection 1044579 - 2018-02-12
- FDA Inspection 974553 - 2016-05-10
- FDA Inspection 891879 - 2014-08-18
- FDA Inspection 782148 - 2012-05-17
- FDA Inspection 700002 - 2010-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.